Mass Extraction All-in-One Solution for Nonporous Pharmaceutical Containers

Source: Press release Pfeiffer Vacuum 1 min Reading Time

Related Vendors

Pfeiffer Vacuum has launched Speedair 3050, an all-in-one solution for nonporous pharmaceutical containers. The solution offers a comprehensive global non-destructive testing approach for containers.

Speedair 3050 from Pfeiffer Vacuum.(Source:  Pfeiffer Vacuum)
Speedair 3050 from Pfeiffer Vacuum.
(Source: Pfeiffer Vacuum)

Pfeiffer Vacuum introduces the new leak tester Speedair 3050, an all-in-one solution for nonporous pharmaceutical containers. Speedair offers a CCIT solution for a wide range of products: Whether the products are flexible or rigid, liquid or solid, the solution can swiftly and accurately test them all. Typically requiring only 30 - 45 seconds, this mass extraction instrument quickly and efficiently delivers results, states the company.

With testing times as short as 30 - 45 seconds, it delivers reliable results, ensuring the integrity of pharmaceutical containers. Unlike alternative methods that focus on specific areas or access points, the Speedair provides a comprehensive global Non-Destructive Testing (NDT) approach for containers. It adheres to ASTM Standard F3287-17, demonstrating the capability in independent third-party labs to 1 micron using an air-based technology.

According to the firm, when it comes to liquid products, the solution stands out as the most sensitive air-based technology available today. Results are repeatable and reliable – eliminating risks associated with false negatives and positives.

The Speedair is fully compliant with industry standards. It utilizes the USP <1207> recognized Mass Extraction technology and operates with FDA 21 CFR Part 11 compliant software, ensuring the testing processes meet the highest regulatory standards, concludes the company.

(ID:49781948)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent